Film Television Auditions – Lifestyle
Author:
CervoMed Inc.
CervoMed Announces New Data at the 2026 AAN Annual Meeting that Demonstrated Neflamapimod Increased Basal Forebrain Volume and Functional Connectivity in Dementia with Lewy Bodies
April 22, 2026
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
April 7, 2026
CervoMed Announces New Data at the AD/PD™ 2026 Scientific Conference that Reinforce Neflamapimod’s Positive Effects in Dementia with Lewy Bodies (DLB) in Patients without Alzheimer’s Disease Co-Pathology
March 19, 2026
CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
March 17, 2026
CervoMed Announces Presentations at Upcoming AD/PD™ 2026 Scientific Conference
March 12, 2026